Doxorubicin retention and chemoresistance in human mesothelioma cell lines
- 15 May 1994
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 57 (4) , 581-585
- https://doi.org/10.1002/ijc.2910570423
Abstract
Eight cell lines were established from the pleural effusion of 4 patients with malignant mesothelioma. The most sensitive (FCCMES‐4) and the most resistant (FCCMES‐2) mesothelioma cell lines had IC50 of 0.66 and 1.85 μM for doxorubicin in clonogenic assays, respectively. In comparison with murine leukemic P388 cells, mesothelioma cell lines were 7.5‐ to 21 ‐fold more resistant to doxorubicin. Co‐incubation with verapamil significantly increased doxorubicin retention in one of the cell lines (FCCMES‐2) expressing P‐glycoprotein in 16.8% of the cells. These results indicate that doxorubicin resistance may be intrinsic in refractory mesothelioma patients and P‐glycoprotein‐mediated drug efflux may be involved in resistance of some of the mesotheliomas.Keywords
This publication has 18 references indexed in Scilit:
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsPublished by Elsevier ,2003
- Usefulness of the nude mouse model in mesothelioma based on a direct patient–xenograft comparisonCancer, 1991
- Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusionsInternational Journal of Cancer, 1991
- Comparison of three commercially available antibodies for flow cytometric monitoring of P‐glycoprotein expression in tumor cellsCytometry, 1991
- Anthracycline resistance in murine leukemic P388 CELLSBiochemical Pharmacology, 1990
- Immunohistochemical Analysis of Pulmonary and Pleural Tumors with the Monoclonal Antibody HYB-612 Directed against the Multidrug Resistance (MDR-1) Gene Product, P-GlycoproteinTumor Biology, 1988
- Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers.Journal of Clinical Oncology, 1988
- Patterns of anthracycline retention modulation in human tumor cellsCytometry, 1987
- Malignant mesothelioma. The eastern cooperative oncology group (ECOG) experienceCancer, 1983
- The Epidemiology of MesotheliomaOccupational Medicine, 1983